Sieve Analysis in HIV-1 Vaccine Efficacy Trials

Current Opinion in HIV and AIDS - United States
doi 10.1097/coh.0b013e328362db2b
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Correction: Comprehensive Sieve Analysis of Breakthrough HIV-1 Sequences in the RV144 Vaccine Efficacy Trial

PLoS Computational Biology
Molecular NeuroscienceEvolutionEcologyGeneticsBehaviorMolecular BiologySystematicsSimulationCellularComputational TheoryMathematicsModeling
2016English

Lessons Drawn From Recent HIV Vaccine Efficacy Trials

Journal of Acquired Immune Deficiency Syndromes
Infectious DiseasesPharmacology
2010English

Willingness to Participate in HIV Vaccine Efficacy Trials in a Population of Fishing Communities, Uganda

Retrovirology
VirologyInfectious Diseases
2012English

Lessons Learned From HIV-1 Vaccine Trials: New Priorities and Directions

Nature Immunology
AllergyImmunology
2013English

Sensitivity Analysis for the Assessment of Causal Vaccine Effects on Viral Load in HIV Vaccine Trials

Biometrics
StatisticsGeneticsProbabilityMolecular BiologyBiochemistryApplied MathematicsMicrobiology ImmunologyBiological SciencesMedicineAgricultural
2003English

Inclusion of South African Adolescents in HIV Vaccine Trials

Journal of AIDS and HIV Research
2012English

Efficacy Trials and Progress of HIV Vaccines

Journal of Cell Science & Therapy
2017English

Preventive Misconception and Adolescents’ Knowledge About HIV Vaccine Trials

Journal of Medical Ethics
ArtsHumanitiesLegal AspectsHealth PolicyHealthEthicsIssues
2013English

T-Cell Based Sieve Analysis Ties HLA A*02 to Vaccine Efficacy and IgA-C1 Immune Correlate in RV144 Thai Trial

Retrovirology
VirologyInfectious Diseases
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy